Health Newstrack

Track health news daily at HealthNewstrack.com

vemurafenib

Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that…

Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled…


The U.S. Food and Drug Administration recently approved Zelboraf (vemurafenib), a drug to treat patients with late-stage (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous…

Research Methodology
White Box Theme : Skin: Blue Majestic | Version: 25.09 | Second: 0.588 | Queries: 73 | 2016-12-04 03:14:04
Alexa Traffic Rank - Global: 1067853 | 0: 0